121 related articles for article (PubMed ID: 21158211)
1. Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT).
Reiter EO; Mauras N; McCormick K; Kulshreshtha B; Amrhein J; De Luca F; O'Brien S; Armstrong J; Melezinkova H
J Pediatr Endocrinol Metab; 2010 Oct; 23(10):999-1009. PubMed ID: 21158211
[TBL] [Abstract][Full Text] [Related]
2. Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
Mitre N; Lteif A
J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1163-7. PubMed ID: 20333877
[TBL] [Abstract][Full Text] [Related]
3. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
[TBL] [Abstract][Full Text] [Related]
4. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
Lenz AM; Shulman D; Eugster EA; Rahhal S; Fuqua JS; Pescovitz OH; Lewis KA
Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
Tessaris D; Matarazzo P; Mussa A; Tuli G; Verna F; Fiore L; Lala R
Endocr J; 2012; 59(2):111-7. PubMed ID: 22068112
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Boccardo F; Rubagotti A; Battaglia M; Di Tonno P; Selvaggi FP; Conti G; Comeri G; Bertaccini A; Martorana G; Galassi P; Zattoni F; Macchiarella A; Siragusa A; Muscas G; Durand F; Potenzoni D; Manganelli A; Ferraris V; Montefiore F
J Clin Oncol; 2005 Feb; 23(4):808-15. PubMed ID: 15681525
[TBL] [Abstract][Full Text] [Related]
7. Testotoxicosis: current viewpoint.
Reiter EO; Norjavaara E
Pediatr Endocrinol Rev; 2005 Dec; 3(2):77-86. PubMed ID: 16361981
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic gonadotropin-independent precocious puberty - is regular surveillance required?
Arya VB; Davies JH
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):403-407. PubMed ID: 30849047
[TBL] [Abstract][Full Text] [Related]
9. Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients.
Boccardo F; Rubagotti A; Battaglia M; Zattoni F; Bertaccini A; Romagnoli A; Conti G
Int J Biol Markers; 2006; 21(2):123-6. PubMed ID: 16847815
[TBL] [Abstract][Full Text] [Related]
10. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.
Kreher NC; Pescovitz OH; Delameter P; Tiulpakov A; Hochberg Z
J Pediatr; 2006 Sep; 149(3):416-20. PubMed ID: 16939760
[TBL] [Abstract][Full Text] [Related]
11. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
Bedognetti D; Rubagotti A; Conti G; Francesca F; De Cobelli O; Canclini L; Gallucci M; Aragona F; Di Tonno P; Cortellini P; Martorana G; Lapini A; Boccardo F
Eur Urol; 2010 Feb; 57(2):238-45. PubMed ID: 19481335
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
Eyssette-Guerreau S; Pinto G; Sultan A; Le Merrer M; Sultan C; Polak M
J Pediatr Endocrinol Metab; 2008 Oct; 21(10):995-1002. PubMed ID: 19209621
[TBL] [Abstract][Full Text] [Related]
13. An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium Study.
Klotz L; Drachenberg D; Singal R; Aprikian A; Fradet Y; Kebabdjian M; Zarenda M; Chin J
Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):320-4. PubMed ID: 25179591
[TBL] [Abstract][Full Text] [Related]
14. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.
Feuillan P; Calis K; Hill S; Shawker T; Robey PG; Collins MT
J Clin Endocrinol Metab; 2007 Jun; 92(6):2100-6. PubMed ID: 17405850
[TBL] [Abstract][Full Text] [Related]
15. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Mieszczak J; Lowe ES; Plourde P; Eugster EA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
[TBL] [Abstract][Full Text] [Related]
16. Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
Zanardi S; Puntoni M; Maffezzini M; Bandelloni R; Mori M; Argusti A; Campodonico F; Turbino L; Branchi D; Montironi R; Decensi A
Cancer Prev Res (Phila); 2009 Apr; 2(4):377-84. PubMed ID: 19336728
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole.
Riepe FG; Baus I; Wiest S; Krone N; Sippell WG; Partsch CJ
Horm Res; 2004; 62(3):113-8. PubMed ID: 15273427
[TBL] [Abstract][Full Text] [Related]
18. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.
Iversen P; McLeod DG; See WA; Morris T; Armstrong J; Wirth MP;
BJU Int; 2010 Apr; 105(8):1074-81. PubMed ID: 22129214
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.
Mauras N; Bishop K; Merinbaum D; Emeribe U; Agbo F; Lowe E
J Clin Endocrinol Metab; 2009 Aug; 94(8):2975-8. PubMed ID: 19470631
[TBL] [Abstract][Full Text] [Related]
20. A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.
Ho TH; Nunez-Nateras R; Hou YX; Bryce AH; Northfelt DW; Dueck AC; Wong B; Stanton ML; Joseph RW; Castle EP
Clin Genitourin Cancer; 2017 Apr; 15(2):196-202.e1. PubMed ID: 27771244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]